Gait Trainer Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 371.89 Million |
| Market Size (2029) | USD 509.71 Million |
| CAGR (2024 - 2029) | 6.51 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Gait Trainer Market Analysis
The Gait Trainer Market size is estimated at USD 371.89 million in 2024, and is expected to reach USD 509.71 million by 2029, growing at a CAGR of 6.51% during the forecast period (2024-2029).
The key factors propelling the market growth include the rising prevalence of conditions affecting gait, increasing cases of injuries related to walking disability, and emerging product technology.
Various diseases, such as neurological diseases, musculoskeletal disorders, cerebral palsy, and skeletal deformities, are increasing the incidence of walking disabilities. Conditions such as Parkinson's disease, stroke, and multiple sclerosis can impair balance and coordination, increasing the need for gait trainers for rehabilitation and mobility assistance. Moreover, injuries, arthritis, and other musculoskeletal issues can limit mobility, marking gait trainers valuable tools for regaining strength and independence.
The gait trainer market is expected to propel due to increasing disorders such as cerebral palsy and skeletal deformities. Musculoskeletal disorder is a disorder that leads to restricted mobility, and it is one of the significant contributors worldwide to disability. For instance, according to a report published by the Movement Disorder Journal in December 2023, Parkinson's disease impacts approximately 8.5 million individuals globally, with a prevalence rate of 315 per 100,000 people. Parkinson's disease affects both environmental and genetic factors, which may lead to regional variations in its prevalence.
Similarly, according to a report published by the Lancet Regional Health, in May 2024, in China, 508.4 thousand cases of Parkinson's disease were reported, with a total of 5.077 million individuals living with the condition in the country. The incidence rate of Parkinson's disease stood at 35.7 per 100,000 population, while the prevalence rate was 356.8 per 100,000 population.
Moreover, the rising number of sports injuries globally is also propelling the growth of the gait trainer market. For instance, according to a report published by the Injury Prevention Journal in August 2023, the annual incidence rate of injuries across various activities was recorded at 5.40 injuries per 100,000 participants. The report also highlighted notable disparities by gender and activity type, with men experiencing a higher incidence rate of 6.44 per 100,000 compared to women at 3.34 per 100,000. Sporting activities exhibited the highest incidence rate at 9.88 per 100,000, surpassing cycling at 2.81 per 100,000, fitness-related activities at 0.21 per 100,000, and walking at 0.03 per 100,000. Such injuries are expected to propel the demand for gait trainers, boosting market growth.
Also, the increasing number of gait training device launches and partnerships among market players to expand gait trainer solutions may significantly contribute to the market's growth during the forecast period. For instance, in January 2022, Clalit Health Services, a Health Maintenance Organization in Israel, and GaitBetter, a provider of a motor-cognitive intervention for gait rehabilitation and falls prevention, partnered to launch GaitBetter's innovative system for Clalit's 4.7 million patients in several locations across Israel. Such launches are expected to expand the company's market position of advanced training devices, propelling the market growth during the forecast period.
Thus, the abovementioned factors, such as the high burden of neurological and musculoskeletal disorders, are expected to drive the market's growth during the forecast period. However, the high cost of instruments is expected to restrain the growth of the gait trainer market over the forecast period.
Gait Trainer Market Trends
The Neurological Disorder Segment is Expected to Hold a Major Market Share in the Gait Trainer Market Over the Forecast Period.
A gait trainer is used in the treatment of various neurological diseases such as cerebral palsy, spinal cord injuries, muscular dystrophy, Parkinson's disease, and multiple sclerosis, as these disorders lead to severe disability and affect motor, sensory, automatic, and neurocognitive functions. The high burden of neurological disorders such as cerebral palsy and multiple sclerosis is expected to drive the neurological disorder segment. The rising research studies involving gait trainers also contribute to the segment's growth during the forecast period.
For instance, according to a report published by the Neuroepidemiology Journal in December 2023, in Portugal, the prevalence of multiple sclerosis was 64 cases per 100,000 individuals, with an incidence rate of 3.1 cases per 100,000 individuals per year.
Additionally, novel technological advancements by various market players may contribute to the growth of the studied segment during the forecast period. For example, in October 2022, Technopark-incubated startup Genrobotics developed a robot-assisted gait training solution called G-Gaiter for the faster rehabilitation of paraplegic patients. G-Gaiter helps people recover from paraplegic conditions brought on by spinal cord injuries, strokes, Parkinson's, multiple sclerosis, and cerebral palsy.
Similarly, in October 2023, TEDIRO GmbH launched its mobile robot for gait trainers, THERY. It is a mobile robot that enables patients to complete autonomous gait training on forearm supports without the assistance of a therapist. Such technologically advanced launches are expected to drive the growth of the studied segment during the forecast period, as well as exergaming studies, which were associated with changes in balance and quality of life.
Therefore, technological advancements in robotic gait trainers are significantly driving growth in the neurological disorder treatment segment, supported by innovations aimed at enhancing rehabilitation outcomes for conditions like spinal cord injuries, strokes, and cerebral palsy.
North America is Expected to Hold a Significant Share in the Market During the Forecast Period
North America is anticipated to hold a significant market share owing to various factors, such as the high prevalence of neurological and musculoskeletal disorders, the rising number of road accidents, the increasing number of product launches, and the high concentration of market players in the region.
For instance, according to a report published by the Centers for Disease Control and Prevention in February 2024, in 2022, the age-adjusted prevalence of diagnosed arthritis among adults stood at 18.9%. Women exhibited a higher likelihood of arthritis at 21.5%, compared to men at 16.1%. Furthermore, there was a notable increase in arthritis prevalence corresponding with age, starting at 3.6% among adults aged 18–34 and peaking at 53.9% among individuals aged 75 and above. These statistics underscore the importance of targeted strategies for arthritis management and prevention, particularly among demographic segments where prevalence rates are elevated.
Similarly, the high number of road accidents is also propelling the growth of the gait trainer market in the region. For instance, according to a report published by the Government of Canada in May 2024, the number of injuries due to accidents in Canada was 118.85 thousand in 2022. The high number of injuries from road accidents is driving demand for gait trainers in the market, as they are essential rehabilitation tools for patients recovering from mobility impairments caused by such injuries.
Moreover, the increasing number of clinical trial studies in the region utilizing gait trainers has also contributed significantly to market growth. For instance, a report published by the BMJ Open Sport & Exercise Medicine in November 2022 included 20 runners suffering from exercise-related lower leg pain. The study found that combining home exercises (HEs) with outdoor gait training improved self-reported pain, function, and movement patterns during outdoor running more than HEs alone. This study was sponsored by the University of Virginia. Hence, the rising number of clinical trials involving gait training is expected to drive market growth in the region.
Therefore, the market growth in North America is expected to accelerate during the forecast period, owing to several factors, such as the high number of accidents and rising clinical trial activities for gait trainers.
Gait Trainer Industry Overview
The gait trainer market is semi-consolidated in nature due to the presence of several companies operating globally and regionally. Some companies currently dominating the market are adapting novel growth strategies such as product launches, acquisitions, and mergers to cater to the rising demand for gait trainers. Major players in the market include Meyland-Smith AS, medica Medizintechnik GmbH, Rex Bionics Ltd, Rewalk Robotics, Hocoma, Alter G Inc., Biodex Medical System, Rifton Equipment, US Bionics Inc. and Ekso Bionics.
Gait Trainer Market Leaders
-
Rifton Equipment
-
Biodex Medical System
-
Rex Bionics Ltd.
-
ReWalk Robotics
-
DIH Medical Group (Hocoma)
*Disclaimer: Major Players sorted in no particular order
Gait Trainer Market News
- May 2024: Advance Rehab Centre launched its new robotic gait training device, LEXO, in Australia. LEXO is a gait rehabilitation for those presenting with stroke, brain or spinal cord injury, multiple sclerosis, Parkinson’s disease, cerebral palsy, and many other neurological conditions.
- January 2024: Ekso Bionics Holdings Inc. introduced GaitCoach, its advanced gait therapy software designed for the EksoNR. GaitCoach offers comprehensive gait therapy support for a wide range of patients utilizing the EksoNR. This innovative software streamlines the use of robotic technology, aiming to enhance user confidence, deliver meaningful, real-time feedback, and provide precise guidance, effectively serving as an additional clinical resource.
Gait Trainer Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Prevalence of Conditions Affecting Gait and the Increasing Cases of Injuries Related to Walking Disability
- 4.2.2 Technological Advancements
-
4.3 Market Restraints
- 4.3.1 High Cost Instrument
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
-
5.1 By Product Type
- 5.1.1 Gait Trainer Walker
- 5.1.2 Exoskeleton
- 5.1.3 Treadmill System
- 5.1.4 Accessories
-
5.2 By Application
- 5.2.1 Orthopedic Disorders
- 5.2.2 Neurological Disorders
- 5.2.3 Amputation
- 5.2.4 Other Applications
-
5.3 By Age
- 5.3.1 Adult
- 5.3.2 Pediatric
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Biodex Medical System
- 6.1.2 DIH Medical Group (Hocoma)
- 6.1.3 Ekso Bionics
- 6.1.4 KTWO Healthcare Private Limited
- 6.1.5 Otto Bock Inc.
- 6.1.6 ReWalk Robotics
- 6.1.7 Rex Bionics Ltd
- 6.1.8 Rifton Equipment
- 6.1.9 Tyromotion GmbH
- 6.1.10 US Bionics Inc.
- 6.1.11 V. Guldmann AS
- 6.1.12 Vermund Larsen AS
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityGait Trainer Industry Segmentation
As per the scope of the report, a gait trainer is a device that assists people with improper gait skills in walking and balancing due to various disorders.
The gait trainer market is segmented by product type, application, age, and geography. By product type, the market is segmented into gait trainer walker, exoskeleton, and treadmill system and accessories. The application segment is further divided into orthopedic disorders, neurological disorders, amputation, and others. By age, the market is segmented into adult and pediatric. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the market sizes and forecasts in terms of value (USD) for the above segments.
| By Product Type | Gait Trainer Walker | |
| Exoskeleton | ||
| Treadmill System | ||
| Accessories | ||
| By Application | Orthopedic Disorders | |
| Neurological Disorders | ||
| Amputation | ||
| Other Applications | ||
| By Age | Adult | |
| Pediatric | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Gait Trainer Market Research FAQs
How big is the Gait Trainer Market?
The Gait Trainer Market size is expected to reach USD 371.89 million in 2024 and grow at a CAGR of 6.51% to reach USD 509.71 million by 2029.
What is the current Gait Trainer Market size?
In 2024, the Gait Trainer Market size is expected to reach USD 371.89 million.
Who are the key players in Gait Trainer Market?
Rifton Equipment, Biodex Medical System, Rex Bionics Ltd., ReWalk Robotics and DIH Medical Group (Hocoma) are the major companies operating in the Gait Trainer Market.
Which is the fastest growing region in Gait Trainer Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Gait Trainer Market?
In 2024, the North America accounts for the largest market share in Gait Trainer Market.
What years does this Gait Trainer Market cover, and what was the market size in 2023?
In 2023, the Gait Trainer Market size was estimated at USD 347.68 million. The report covers the Gait Trainer Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Gait Trainer Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Gait Trainer Industry Report
Statistics for the 2024 Gait Trainer market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Gait Trainer analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
